← Evidence map

ArticleTrials2023

Adjuvant melatonin for uveal melanoma (AMUM): protocol for a randomized open-label phase III study.

Ruba Kal Omar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

4 papers cite it

2023
2024
2025
2026
this papercites it

The trial

Full record →Abstract, authors, funding and every citing paper · PMID 36966349